Psoriasis and Cardiovascular Risk: Strength in Numbers, Part II
- 1 May 2011
- journal article
- editorial
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 131 (5) , 1007-1010
Abstract
No abstract availableKeywords
Funding Information
- American College of Cardiology Foundation (K23HL097151-01)
- National Institutes of Health (RO1HL089744)
- British Association of Dermatologists
- National Heart, Lung, and Blood Institute
- National Psoriasis Foundation
This publication has 29 references indexed in Scilit:
- Prevalence of the Metabolic Syndrome in PsoriasisArchives of Dermatology, 2011
- Validity of The Health Improvement Network (THIN) for the study of psoriasisBritish Journal of Dermatology, 2010
- Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K.British Journal of Dermatology, 2010
- Psoriasis and Cardiovascular Risk: Strength in NumbersJournal of Investigative Dermatology, 2010
- EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritisAnnals of the Rheumatic Diseases, 2010
- Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research DatabaseEuropean Heart Journal, 2009
- The Risk of Stroke in Patients with PsoriasisJournal of Investigative Dermatology, 2009
- Uric Acid and Cardiovascular RiskNew England Journal of Medicine, 2008
- Cause-Specific Excess Deaths Associated With Underweight, Overweight, and ObesityJAMA, 2007
- Is an internal comparison better than using national data when estimating mortality in longitudinal studies?Journal of Epidemiology and Community Health, 2006